EZH, a.s. Competitors

Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders. Thirty medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines. Roche has been recognised as the Group Leader in sustainability within the Pharmaceuticals, Biotechnology & Life Sciences Industry ten years in a row by the Dow Jones Sustainability Indices (DJSI). For more information, please visit https://careers.roche.com Read our community guidelines here: https://www.roche.com/some-guidelines.htm #Roche #Biotechnology #Pharmaceuticals #Diagnostics #Healthcare #PersonalisedHealthcare #GreatPlaceToWork #Innovation

Jesteśmy zintegrowanym koncernem multienergetycznym, prowadzącym działalność w Europie Środkowej i Kanadzie. Zapewniamy energię i paliwa ponad 100 milionom Europejczyków, a nasze zaawansowane produkty dostępne są w blisko 90 krajach na 6 kontynentach. Konsekwentnie budujemy pozycję regionalnego lidera transformacji energetycznej, wdrażając czyste, przyjazne środowisku technologie oraz energetykę opartą o nisko- i zeroemisyjne źródła wytwarzania. Nasze działania podporządkowane są realizacji strategii osiągnięcia neutralności emisyjnej do 2050 roku. We are an integrated, multi-utility company, operating in Central Europe and Canada. We provide energy and fuel to over 100 million of Europeans, while our advanced products are marketed to over 90 countries across 6 continents. We pursue strengthening our position of a regional leader in energy transition by implementing clean and sustainable technologies, as well as power generation based on low- and zero-emission sources. Our actions are driven by a strategic goal of reaching emission neutrality by 2050.

Karolinska Institutet is one of the world´s leading medical universities. Our mission is to contribute to the improvement of human health through research and education. Karolinska Institutet accounts for over 40 per cent of the medical academic research conducted in Sweden and offers the country´s broadest range of education in medicine and health sciences. Since 1901 the Nobel Assembly at Karolinska Institutet has selected the Nobel laureates in Physiology or Medicine. Karolinska Institutet was founded by King Karl XIII in 1810 as an "academy for the training of skilled army surgeons". Today, Karolinska Institutet is a modern medical university and one of the foremost in the world. With our close relationship to the clinical milieu, a well established infrastructure and a stable financial situation, Karolinska Institutet has excellent prerequisites for sustaining high quality research and education.